BRAF V600E-mutant mCRC
The first and only treatment approved specifically for patients with BRAF V600E-mutant mCRC, who have received prior systemic therapy1,2
BRAFV600E-mutant mCRC
is an area of high unmet need2-13
![unmet need](/sites/braftovi/files/2023-10/HD_unmet_need_site_P02.jpg)
![unmet need](/sites/braftovi/files/2023-10/HD_unmet_need_site_P03.jpg)
![unmet need](/sites/braftovi/files/2023-10/HD_unmet_need_site_P04.jpg)
![unmet need](/sites/braftovi/files/2023-10/HD_unmet_need_site_P05.jpg)
![unmet need](/sites/braftovi/files/2023-10/HD_unmet_need_site_P06.jpg)